Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

668
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
668
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

719
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
719
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

340
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
340
Survival Tree01:19

Survival Tree

497
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
497
How Data are Classified: Categorical Data01:11

How Data are Classified: Categorical Data

48.6K
A variable, usually notated by capital letters such as X and Y, is a characteristic or measurement that can be determined for each member of a population. Data are the actual values of variables. They may be numbers, or they may be words. Datum is a single value.
Data are classified based on whether they are measurable or not. Categorical data cannot be measured; instead, it can be divided into categories. For example, if Y denotes a person's party affiliation, some examples of Y include...
48.6K
Contingency Table01:29

Contingency Table

5.0K
A contingency table provides a way of portraying data that can facilitate calculating probabilities. It is a method of displaying a frequency distribution as a table with rows and columns to show how two variables may be dependent (contingent) upon each other; The table helps determine conditional probabilities quite quickly and can help systematically organize, analyze and quantify data. The table displays sample values concerning two variables that may be dependent or contingent on one...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalizing N-of-1 Trial Results to Facilitate Decision-Making.

JAMA network open·2026
Same author

Diagnosis of Alzheimer's disease and related dementias and outmigration of older Puerto Rican Medicare Fee-for-service beneficiaries, 2012-2019.

The journals of gerontology. Series B, Psychological sciences and social sciences·2026
Same author

Evidence for Evidence-Based Medicine - A Call for Some Theory and a New Problem.

NEJM evidence·2026
Same author

Digital N-of-1 trials and their application in experimental physiology.

Experimental physiology·2026
Same author

Selected Impacts of Urban Heat Islands on Emergency Medical Services Utilization in Rhode Island.

The western journal of emergency medicine·2026
Same author

End-Stage Renal Disease Treatment Choices Model and Use of Home Dialysis and Kidney Transplant.

JAMA health forum·2026

Related Experiment Video

Updated: Apr 11, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Bayesian network meta-analysis for unordered categorical outcomes with incomplete data.

Christopher H Schmid1,2, Thomas A Trikalinos3,2, Ingram Olkin4

  • 1Department of Biostatistics, Brown University School of Public Health, Providence, RI, USA.

Research Synthesis Methods
|June 9, 2015
PubMed
Summary

High-dose statins effectively reduce cardiovascular disease risk. This study introduces a new Bayesian model for analyzing complex treatment effects across multiple outcomes, even with incomplete data.

Keywords:
Markov chain Monte Carlocorrelated outcomesmissing datamultinomial distributionmultiple treatments meta-analysisstatin therapy

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K

Related Experiment Videos

Last Updated: Apr 11, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K

Area of Science:

  • Biostatistics
  • Cardiovascular Research
  • Clinical Trials

Background:

  • Network meta-analysis is crucial for comparing multiple treatments across various outcomes.
  • Handling partially observed data in meta-analyses presents significant challenges.
  • Categorical outcomes require specialized statistical approaches for accurate analysis.

Purpose of the Study:

  • To develop a novel Bayesian multinomial network meta-analysis model for unordered categorical outcomes.
  • To accommodate partially observed data where exact event counts are unknown.
  • To enable robust comparison and ranking of treatments across multiple outcomes.

Main Methods:

  • A Bayesian multinomial network meta-analysis model was developed.
  • The model accounts for correlations within mutually exclusive categories.
  • Applied to 17 trials comparing high-dose statins, low-dose statins, and standard care for cardiovascular outcomes.

Main Results:

  • High-dose statins demonstrated effectiveness in reducing the risk of cardiovascular disease.
  • The model successfully analyzed both complete and partially observed outcome data.
  • Multinomial and network representations confirmed treatment efficacy.

Conclusions:

  • The developed Bayesian model is effective for analyzing complex categorical outcomes in network meta-analyses.
  • High-dose statins are a beneficial treatment for reducing cardiovascular disease risk.
  • The model's ability to handle incomplete data enhances its applicability in real-world research.